Satadal Chatterjee

795 total citations
23 papers, 656 citations indexed

About

Satadal Chatterjee is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Satadal Chatterjee has authored 23 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Satadal Chatterjee's work include Cancer therapeutics and mechanisms (8 papers), PARP inhibition in cancer therapy (8 papers) and DNA Repair Mechanisms (4 papers). Satadal Chatterjee is often cited by papers focused on Cancer therapeutics and mechanisms (8 papers), PARP inhibition in cancer therapy (8 papers) and DNA Repair Mechanisms (4 papers). Satadal Chatterjee collaborates with scholars based in United States and India. Satadal Chatterjee's co-authors include Nathan A. Berger, Cecilia M. Whitacre, Sosamma J. Berger, S J Berger, Lili Liu, Pietro Taverna, Stanton L. Gerson, Shirley J. Petzold, Hiroshi Hashimoto and Haruyo Hirota and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Radiation Research.

In The Last Decade

Satadal Chatterjee

23 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satadal Chatterjee United States 14 506 360 62 60 51 23 656
Aaron Nguyen United States 12 695 1.4× 207 0.6× 66 1.1× 65 1.1× 46 0.9× 21 966
Judith Leibovici Israel 15 318 0.6× 238 0.7× 33 0.5× 59 1.0× 40 0.8× 83 698
Takashi Tsuruo Japan 11 349 0.7× 313 0.9× 44 0.7× 30 0.5× 21 0.4× 16 532
Kamila Wolanin Poland 10 456 0.9× 261 0.7× 89 1.4× 44 0.7× 51 1.0× 13 643
Ukhyun Jo United States 20 782 1.5× 458 1.3× 91 1.5× 148 2.5× 51 1.0× 44 984
Suhlan Wu United States 11 356 0.7× 158 0.4× 14 0.2× 52 0.9× 43 0.8× 11 516
Yanwen Zhou Japan 16 394 0.8× 158 0.4× 28 0.5× 90 1.5× 61 1.2× 34 618
Chris Tse United States 13 386 0.8× 121 0.3× 31 0.5× 36 0.6× 39 0.8× 26 630
Barbara Lamb United States 18 418 0.8× 80 0.2× 51 0.8× 90 1.5× 38 0.7× 27 633
Qiao‐Yang Sun Singapore 15 446 0.9× 105 0.3× 77 1.2× 80 1.3× 109 2.1× 23 675

Countries citing papers authored by Satadal Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Satadal Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satadal Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satadal Chatterjee more than expected).

Fields of papers citing papers by Satadal Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satadal Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satadal Chatterjee. The network helps show where Satadal Chatterjee may publish in the future.

Co-authorship network of co-authors of Satadal Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Satadal Chatterjee. A scholar is included among the top collaborators of Satadal Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satadal Chatterjee. Satadal Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahmad, Mohammad, et al.. (2014). GRP78 up-regulation leads to hypersensitization to cisplatin in A549 lung cancer cells.. PubMed. 34(7). 3493–500. 13 indexed citations
2.
Chatterjee, Satadal & Shobhan Gaddameedhi. (2009). Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: A mechanistic study employing molecular genomics. Journal of Cancer Research and Therapeutics. 5(9). 61–61. 14 indexed citations
3.
Chatterjee, Satadal, et al.. (2003). Down-regulation of topoisomerase IIα is caused by up-regulation of GRP78. Biochemical and Biophysical Research Communications. 300(2). 327–332. 17 indexed citations
4.
Hirota, Haruyo, et al.. (2002). Interference with topoisomerase IIα potentiates melphalan cytotoxicity. International Journal of Oncology. 20(2). 311–8. 7 indexed citations
5.
Chatterjee, Satadal, Sosamma J. Berger, & Nathan A. Berger. (1999). Poly(ADP-ribose) polymerase: A guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Molecular and Cellular Biochemistry. 193(1-2). 23–30. 42 indexed citations
6.
Liu, Lili, Pietro Taverna, Cecilia M. Whitacre, Satadal Chatterjee, & Stanton L. Gerson. (1999). Pharmacologic disruption of base excision repair sensitizes mismatch repair-deficient and -proficient colon cancer cells to methylating agents.. PubMed. 5(10). 2908–17. 124 indexed citations
7.
Chatterjee, Satadal, et al.. (1997). Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78.. PubMed. 57(22). 5112–6. 37 indexed citations
8.
Chatterjee, Satadal, et al.. (1995). Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.. PubMed. 7(7-8). 407–16. 6 indexed citations
9.
Hashimoto, Hisako, Satadal Chatterjee, & Nathan A. Berger. (1995). Inhibition of etoposide (VP-16)-induced DNA recombination and mutant frequency by Bcl-2 protein overexpression.. PubMed. 55(18). 4029–35. 25 indexed citations
10.
Danks, Mary K., et al.. (1995). A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents.. PubMed. 7(1). 21–9. 11 indexed citations
11.
Chatterjee, Satadal, et al.. (1994). Induction of adaptive response by nitrofurantoin against oxidative DNA damage in some bacterial cells. Mutation Research/Genetic Toxicology. 321(3). 127–132. 4 indexed citations
12.
13.
Chatterjee, Satadal, et al.. (1994). Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens.. PubMed. 6(6). 269–79. 52 indexed citations
14.
Mukherjee, U., et al.. (1992). Adaptive response of vibrio cholerae and escherichia coli to nitrofurantoin. Environmental and Molecular Mutagenesis. 20(1). 53–60. 6 indexed citations
15.
Chatterjee, Satadal, Ming Cheng, Sosamma J. Berger, & Nathan A. Berger. (1991). Alkylating Agent Hypersensitivity in Poly(Adenosine Diphosphate-Ribose) Polymerase Deficient Cell Lines. PubMed. 3(3). 71–75. 16 indexed citations
16.
Mukherjee, U., et al.. (1990). DNA damage and cell killing by nitrofurantoin in relation to its carcinogenic potential.. PubMed. 11(4). 275–87. 10 indexed citations
17.
Chatterjee, Satadal, Nora V. Hirschler, Shirley J. Petzold, Sosamma J. Berger, & Nathan A. Berger. (1989). Mutant cells defective in poly(ADP-ribose) synthesis due to stable alterations in enzyme activity or substrate availability. Experimental Cell Research. 184(1). 1–15. 44 indexed citations
18.
Chatterjee, Satadal, Shirley J. Petzold, Sosamma J. Berger, & Nathan A. Berger. (1987). Strategy for selection of cell variants deficient in poly(ADP-ribose) polymerase. Experimental Cell Research. 172(2). 245–257. 20 indexed citations
19.
Chatterjee, Satadal, et al.. (1984). UV non-mutable mutant from V-79 Chinese hamster cells. Molecular and General Genetics MGG. 193(2). 251–254. 6 indexed citations
20.
Chatterjee, Satadal, et al.. (1982). Survival and mutation of Chinese hamster cells after ultraviolet irradiation and caffeine treatment. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 106(1). 137–146. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Nguyen Breakdown of academic impact, for papers by Judith Leibovici Breakdown of academic impact, for papers by Takashi Tsuruo Breakdown of academic impact, for papers by Kamila Wolanin Breakdown of academic impact, for papers by Ukhyun Jo Breakdown of academic impact, for papers by Suhlan Wu Breakdown of academic impact, for papers by Yanwen Zhou Breakdown of academic impact, for papers by Chris Tse Breakdown of academic impact, for papers by Barbara Lamb Breakdown of academic impact, for papers by Qiao‐Yang Sun
Rankless by CCL
2026